Global eClinical Solutions Growth Opportunities

Global eClinical Solutions Growth Opportunities

Decentralized Clinical Trials, Rising Mobile Health Adoption, and Cloud-based Platforms Lower Costs and Enhance Efficiency

RELEASE DATE
03-Mar-2022
REGION
North America
Deliverable Type
Market Research
Research Code: K632-01-00-00-00
SKU: HC03501-GL-MT_26264
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC03501-GL-MT_26264

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

The COVID-19 pandemic impact on the biopharmaceutical industry has increased patient-centricity and the adoption of eClinical services digital platforms to manage clinical development programs. Capital investments and co-development recorded an uptick over the last 2 years, focusing on advancing clinical assets and expanding the number of Phase 2 and 3 clinical trials. The total number of open trials (recruiting, enrolling by invitations) in 2021 went up 1.8x compared to 2019.

eClinical solutions are the backbone for effectively managing clinical trials end-to-end. The market will register sustained growth at a 14.8% CAGR from 2021, reaching $9,409.5 million by 2026. Cloud-based electronic data capture (EDC), randomization and trial supply management (RTSM)/interactive response technology (IRT), and integrated platforms provide biopharmaceutical sponsors a unified view of the trial workflow while improving efficiency. Beyond the data management and operations products suite, clinical trial IT vendors have the opportunity to create intelligent and connected solutions that focus on decentralized and virtual hybrid trials. Remote patient recruitment and monitoring applications will record significant growth, encompassing patient recruitment, engagement, and monitoring to real-world evidence collection and reporting.

The United States continues to be a dominant market for eClinical solutions, followed by Europe. The rising number of clinical trials, less stringent regulatory guidelines than more developed markets, and large population base in Asia-Pacific offers vendors growth opportunities.

In this report, Frost & Sullivan offers:
• Insights through market forecasts
• Analysis by segment [clinical data management (CDM) and eSourcing, remote patient recruitment and monitoring, and clinical trial operations
management] and region [the United States, Europe, the rest of the world (RoW)]
• Market trends, drivers, and restraints
• Leading participants and their offerings
• Opportunities that stakeholders can pursue over the next 5 years

Author: Amol Dilip Jadhav

Table of Contents

Why Is It Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top Three Strategic Imperatives on the eClinical Solutions Market

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Value Chain

Segmentation by Solution

eClinical Solutions Digital Continuity Trend

eClinical Solutions Overview—Remote Patient Recruitment and Monitoring Subsegments

eClinical Solutions Overview—Remote Patient Recruitment and Monitoring Subsegments (continued)

eClinical Solutions Overview—Clinical Data Management and eSourcing

eClinical Solutions Overview—Clinical Data Management and eSourcing Subsegments

eClinical Solutions Overview—Clinical Data Management and eSourcing Subsegments (continued)

eClinical Solutions Overview—Clinical Trial Operations Management Subsegments

eClinical Solutions Overview—Clinical Trial Operations Management Subsegments (continued)

Segmentation by Region

Key Competitors

Key Growth Metrics

Growth Drivers

Growth Restraints

Evolving Clinical Trial Delivery Models

eClinical Solutions Market Trends

eClinical Solutions Market Trends (continued)

Forecast Assumptions

Revenue Forecast

Revenue Forecast by Segment

Revenue Forecast by Region

Pricing Trends and Revenue Forecast Analysis

Pricing Trends and Revenue Forecast Analysis (continued)

Revenue Forecast Analysis by Segment

Revenue Forecast Analysis by Region

Competitive Environment

Revenue Share

Revenue Share Analysis

Mergers and Acquisitions

Key Growth Metrics

Revenue Forecast

Revenue Forecast by Application

Revenue Forecast by Region

Revenue Forecast Analysis

Revenue Forecast Analysis by Application

Revenue Forecast Analysis by Region

Key Growth Metrics

Revenue Forecast

Revenue Forecast by Application

Revenue Forecast by Region

Revenue Forecast Analysis

Revenue Forecast Analysis by Application

Revenue Forecast Analysis by Region

Key Growth Metrics

Revenue Forecast

Revenue Forecast by Application

Revenue Forecast by Region

Revenue Forecast Analysis

Revenue Forecast Analysis by Application

Revenue Forecast Analysis by Region

Growth Opportunity 1—End-to-end Decentralized Clinical Trial (DCT) Platforms to Ensure Interoperability and Scalability

Growth Opportunity 1—End-to-end Decentralized Clinical Trial (DCT) Platforms to Ensure Interoperability and Scalability (continued)

Growth Opportunity 2—Next-generation Telehealth to Enhance Patient Recruitment and Engagement in Clinical Trials

Growth Opportunity 2—Next-generation Telehealth to Enhance Patient Recruitment and Engagement in Clinical Trials (continued)

Growth Opportunity 3—Smartphone-based Remote Monitoring to Collect RWE and Analytics

Growth Opportunity 3—Smartphone-based Remote Monitoring to Collect RWE and Analytics (continued)

Growth Opportunity 4—Cloud-based EDC to Enable a Cost-effective Solution for Large Phase 3 Trials

Growth Opportunity 4—Cloud-based EDC to Enable a Cost-effective Solution for Large Phase 3 Trials (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

List of Exhibits (continued)

Legal Disclaimer

The COVID-19 pandemic impact on the biopharmaceutical industry has increased patient-centricity and the adoption of eClinical services digital platforms to manage clinical development programs. Capital investments and co-development recorded an uptick over the last 2 years, focusing on advancing clinical assets and expanding the number of Phase 2 and 3 clinical trials. The total number of open trials (recruiting, enrolling by invitations) in 2021 went up 1.8x compared to 2019. eClinical solutions are the backbone for effectively managing clinical trials end-to-end. The market will register sustained growth at a 14.8% CAGR from 2021, reaching $9,409.5 million by 2026. Cloud-based electronic data capture (EDC), randomization and trial supply management (RTSM)/interactive response technology (IRT), and integrated platforms provide biopharmaceutical sponsors a unified view of the trial workflow while improving efficiency. Beyond the data management and operations products suite, clinical trial IT vendors have the opportunity to create intelligent and connected solutions that focus on decentralized and virtual hybrid trials. Remote patient recruitment and monitoring applications will record significant growth, encompassing patient recruitment, engagement, and monitoring to real-world evidence collection and reporting. The United States continues to be a dominant market for eClinical solutions, followed by Europe. The rising number of clinical trials, less stringent regulatory guidelines than more developed markets, and large population base in Asia-Pacific offers vendors growth opportunities. In this report, Frost & Sullivan offers: • Insights through market forecasts • Analysis by segment [clinical data management (CDM) and eSourcing, remote patient recruitment and monitoring, and clinical trial operations management] and region [the United States, Europe, the rest of the world (RoW)] • Market trends, drivers, and restraints • Leading participants and their offerings • Opportunities that stakeholders can pursue over the next 5 years Author: Amol Dilip Jadhav
More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Amol Dilip Jadhav
Industries Healthcare
WIP Number K632-01-00-00-00
Keyword 1 eClinical Solutions
Keyword 2 electronic data capture (EDC)
Keyword 3 clinical data management (CDM)
Is Prebook No
GPS Codes 9564-B1,9575-B1,9600-B1,9612-B1,9571-B1,9568-B1,9611-B1